Table 2.
Treatments delivered for each patient.
| Patient # | Sex | Surgery | Photosensitizer | Neoadjuvant chemotherapy | Radiation fraction size/total dose (cCGE) |
Adjuvant chemotherapy and/or immunotherapy |
|---|---|---|---|---|---|---|
| 1 | Male | ePD | HPPH | Cisplatin and alimta | 235/7500 | Carboplatin and Alimta |
| 2 | Male | ePD | Photofrin | Cisplatin and alimta | 180/5040 | Gemcitabine |
| 3 | Female | ePD | Photofrin | None | 200/7000 | PD1 |
| 4 | Male | ePD | Photofrin | None | 180/5940 | Carboplatin and Alimta |
| 5 | Male | ePD | Photofrin | Carboplatin and Alimta | 200/5400 | Gemcitabine and Carboplatin |
| 6 | Male | ePD | Photofrin | Cisplatin and Alimta | 180/5040 | None |
| 7 | Male | ePD | Photofrin | Carboplatin and Alimta | 180/5040 | None |
| 8 | Male | ePD | HPPH | Cisplatin and Alimta | 200/6000 | Interferon alpha |
| 9 | Male | ePD | Photofrin | Carboplatin and Alimta | 200/5000 | Interferon alpha |
| 10 | Male | ePD | HPPH | None | 200/7000 | Cisplatin and Alimta, Interferon alpha |
ePD, extended pleurectomy/decortication; HPPH, 2-(1-hexyloxytheyl)-2-devinyl pyropheophorbide-a.